@cancerconnector.bsky.social
🚨 New in @JClinInvest 🚨
HPV+ oropharynx patients do not all benefit equally from the same radiation dose.
Our study shows that genomics (via GARD) can guide personalized RT de-escalation—safely sparing toxicity without losing cure.
Paper 👉 doi.org/10.1172/JCI194…#ASTRO2525
HPV+ oropharynx patients do not all benefit equally from the same radiation dose.
Our study shows that genomics (via GARD) can guide personalized RT de-escalation—safely sparing toxicity without losing cure.
Paper 👉 doi.org/10.1172/JCI194…#ASTRO2525
October 1, 2025 at 12:16 AM
🚨 New in @JClinInvest 🚨
HPV+ oropharynx patients do not all benefit equally from the same radiation dose.
Our study shows that genomics (via GARD) can guide personalized RT de-escalation—safely sparing toxicity without losing cure.
Paper 👉 doi.org/10.1172/JCI194…#ASTRO2525
HPV+ oropharynx patients do not all benefit equally from the same radiation dose.
Our study shows that genomics (via GARD) can guide personalized RT de-escalation—safely sparing toxicity without losing cure.
Paper 👉 doi.org/10.1172/JCI194…#ASTRO2525
Looking for a new team member to join us on our journey of discovery.
#mathonco #evolution #antibioticresistance
@cbo.bsky.social @sandyanderson.bsky.social @mathonco.bsky.social @natphys.nature.com @aaas.org
#mathonco #evolution #antibioticresistance
@cbo.bsky.social @sandyanderson.bsky.social @mathonco.bsky.social @natphys.nature.com @aaas.org
September 1, 2025 at 2:42 PM
Looking for a new team member to join us on our journey of discovery.
#mathonco #evolution #antibioticresistance
@cbo.bsky.social @sandyanderson.bsky.social @mathonco.bsky.social @natphys.nature.com @aaas.org
#mathonco #evolution #antibioticresistance
@cbo.bsky.social @sandyanderson.bsky.social @mathonco.bsky.social @natphys.nature.com @aaas.org